Indomethacin and the corneal immune response

Area of Science:

• Ophthalmology
• Immunology
• Pharmacology

Background:

• Ocular inflammation is a significant concern in ophthalmic research.
• Non-corticosteroid anti-inflammatory drugs offer potential therapeutic alternatives.

Purpose of the Study:

• To evaluate the efficacy of locally administered indomethacin in reducing ocular inflammation.
• To assess the impact of indomethacin on antibody formation in an experimental rabbit model.

Main Methods:

• Twenty-six rabbits received daily subconjunctival injections of indomethacin.
• Ocular inflammation was induced via intracorneal injection of bovine gamma globulin.
• Clinical grading, antibody-forming cell counts, and antibody titers were assessed.

Main Results:

• Indomethacin treatment significantly reduced the inflammatory response in rabbit eyes.
• A trend towards an increased number of antibody-forming cells was observed in treated eyes, though not statistically significant.
• Antibody levels in sera and ocular fluids were analyzed.

Conclusions:

• Locally administered indomethacin demonstrates significant anti-inflammatory effects in experimental ocular inflammation.
• Indomethacin may modulate but does not suppress the immune response in this model.